#19Regional leaders 1–100

Ipsen

France · European Union

Peptides and complex injectablesOncology / ADC / high-potencyFinished dosage forms and small molecules

Manufacturing profile

Country
France
Regulatory region
European Union
ISO
FRA

Selection basis

The company is placed in positions 1–100 as a major regional manufacturer, biopharmaceutical group, important generics supplier or manufacturing/CDMO leader.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Peptide synthesis or recombinant upstream
  2. 2Chromatography and UF/DF
  3. 3HPLC/LC-MS and CE peptide mapping
  4. 4Sterile filtration and cartridge/vial filling
  5. 5Particles, sterility, endotoxin and cold-chain release
  6. 6Contained dispensing and high-potency handling
  7. 7Chemical synthesis or biologic upstream
  8. 8Purification and formulation
  9. 9HPLC/LC-MS/CE and potency analytics

Relevant FUZKK packages

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology